April 2026 Newsletter

Our global, grassroots effort brings new hope to families affected by Aspartylglucosaminuria

We are thrilled to share that the U.S. Food and Drug Administration (FDA) has given approval to the start of a clinical trial for the treatment of the ultra-rare disease Aspartylglucosaminuria (AGU) 🧬✨

2024 Happy Holidays From Rare Trait Hope Society!

As we wrap up an incredible year, we at Rare Trait Hope Society want to thank you 🙏 our valued supporters and sponsors 🫶 for being the heart of our mission. Through your generosity, we’re making strides in advancing hope for those impacted by Aspartylglucosaminuria (AGU) and other rare conditions. This holiday newsletter shares excitingContinue reading “2024 Happy Holidays From Rare Trait Hope Society!”